跳至主要内容
临床试验/NCT01188200
NCT01188200已完成3 期

Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes

Abbott Nutrition22 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
168
试验地点
22
主要终点
The primary variable is glucose concentration

研究概览

简要总结

The purpose of this study is to demonstrate the efficacy of a nutritional formula in patients with type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has type 2 diabetes.
  • Subject is over 18 years of age.
  • Subject is a male, or a non-pregnant, non-lactating female.
  • Subject's BMI is > 20 kg/m2 and < 40 kg/m
  • Subject's HbA1c level is 6.5 - 11%.
  • If on a chronic thyroid medication or hormone replacement therapy, subject has been on constant dosage for at least two months prior to Screening Visit.
  • Subject's weight is stable for the past two months prior to Screening Visit.

排除标准

  • Subject uses exogenous insulin, Byetta or alpha-glucosidase inhibitor for glucose control.
  • Subject has type 1 diabetes.
  • Subject has history of diabetic ketoacidosis.
  • Subject has the following: current infection ; has had inpatient surgery or received systemic corticosteroid treatment in the last 3 months; or antibiotics in the last 3 weeks prior to screening.
  • Subject has an active malignancy.
  • Subject has had significant cardiovascular event <6 months prior to study entry or history of congestive heart failure.
  • Subject has end stage organ failure.
  • Subject has history of severe gastroparesis, renal or hepatic disease.
  • Subject has an active metabolic, hepatic, or gastrointestinal disease or condition that may interfere with nutrient absorption, distribution, metabolism, or excretion, excluding diabetes.
  • Subject has a chronic, contagious, infectious disease.
  • Taking daily medications at doses that would interfere with nutrient absorption, metabolism, excretion, gastric motility, or blood glucose.
  • Subject has fainted or experienced other adverse event in response to blood collection prior to enrollment into this study.
  • Clotting or bleeding disorders.
  • Allergic or intolerant to any ingredient found in the test meal.

结局指标

主要结局

The primary variable is glucose concentration

时间窗: 0 to 240 minutes

次要结局

  • Additional measures of glucose concentration(0 to 240 mins)

研究者

申办方类型
Industry

研究点 (22)

Loading locations...

相似试验